SciSparc Acquires MUSE System IP Portfolio from Xylo Technologies

SciSparc Ltd. has signed a binding term sheet to acquire the full portfolio of patents, trademarks, know-how, and related intellectual property rights, primarily associated with the MUSE™ system, from Xylo Technologies Ltd. The MUSE™ system is a single-use endoscopic device designed for transoral fundoplication, a minimally invasive treatment for gastroesophageal reflux disease (GERD). Under the agreement, SciSparc will issue to Xylo ordinary shares representing 19.99% of SciSparc’s issued and outstanding share capital at closing, with the option to issue pre-funded warrants instead. Building on Xylo’s prior commercialization success in Greater China, SciSparc plans to pursue similar partnerships to expand into markets in North America, Europe, and Latin America. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9594397-en) on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)